Comparative nucleic acid transfection efficacy in primary hepatocytes for gene silencing and functional studies.
BACKGROUND
Primary hepatocytes are the best resource for in vitro studies directed at understanding hepatic processes at the cellular and molecular levels, necessary for novel drug development to treat highly prevalent diseases such as non-alcoholic steatohepatitis, cardiovascular disease and type 2 diabetes. There is a need to identify simple methods to genetically manipulate primary hepatocytes and conduct functional studies with plasmids, small interfering RNA (siRNA) or microRNA (miRNA). New lipofection reagents are available that have the potential to yield higher levels of transfection with reduced toxicity.


RESULTS
We have tested several liposome-based transfection reagents used in molecular biology research. We show that transfection efficiency with one of the most recently developed formulations, Metafectene Pro, is high with plasmid DNA (>45% cells) as well as double stranded RNA (>90% with siRNA or microRNA). In addition, negligible cytotoxicity was present with all of these nucleic acids, even if cells were incubated with the DNA:lipid complex for 16 hours. To provide the proof of concept that these conditions can be used not only for overexpression of a gene of interest, but also in RNA interference applications, we targeted two liver expressed genes, Sterol Regulatory Element-Binding Protein-1 and Fatty Acid Binding Protein 5 using plasmid-mediated short hairpin RNA expression. In addition, similar transfection conditions were used to optimally deliver siRNA and microRNA.


CONCLUSIONS
We have identified a lipid-based reagent for primary hepatocyte transfection of nucleic acids currently used in molecular biology laboratories. The conditions described here can be used to expedite a large variety of research applications, from gene function studies to microRNA target identification.
Department of Medical and Molecular Genetics, Indiana University School of Medicine, 975 West Walnut St, IB130, Indianapolis, Indiana 46202, USA. nmorralc@iupui.edu.
Jae-Seung
JS
Park
Sneha
S
Surendran
Lisa M
LM
Kamendulis
Núria
N
Morral
In Vitro. 1981 Oct;17(10):913-25
6273298
Nature. 2001 May 24;411(6836):494-8
11373684
Mol Microbiol. 1992 Nov;6(22):3343-53
1484489
In Vitro. 1981 Oct;17(10):926-34
7309042
Mol Biotechnol. 2004 Oct;28(2):97-103
15477648
Cell. 2005 Nov 18;123(4):607-20
16271386
Cell. 1997 Aug 8;90(3):479-90
9267028
J Neurosci Res. 1999 Dec 15;58(6):831-5
10583914
Hum Gene Ther. 2009 Jan;20(1):87-94
18828727
Trends Cell Biol. 2007 Mar;17(3):118-26
17197185
Nat Cell Biol. 2005 Jul;7(7):719-23
15937477
Cell. 2005 Nov 18;123(4):621-9
16271385
Biochem Pharmacol. 2005 Jun 15;69(12):1805-13
15885657
Genes Dev. 2003 Jan 1;17(1):49-63
12514099
Cell. 2005 Nov 18;123(4):631-40
16271387
Nature. 2002 Jul 11;418(6894):244-51
12110901
J Biol Chem. 2008 Jan 25;283(4):2120-8
18025090
J Biomed Biotechnol. 2009;2009:871313
19707536
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2746-51
16477010
Hepatology. 1994 Aug;20(2):494-514
8045510
Nat Rev Genet. 2008 Feb;9(2):102-14
18197166
Cell. 2005 Jan 14;120(1):15-20
15652477